<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="non-drug-prep" /><meta name="keywords" content="Uvistat preparations" /><meta name="IX" content="Uvistat preparations" /><title>Uvistat®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="6081.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="6081.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=6081.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2080.htm">13 Skin</a> &gt; <a href="6074.htm">13.8 Sunscreens and camouflagers</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="6075.htm" title="Previous: 13.8.1 Sunscreen preparations">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="57565.htm" title="Next: Photodamage">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_6075">13.8.1 Sunscreen preparations</h1><div id="pC" class="jN"><div><p>Solar ultraviolet
irradiation can be harmful to the skin. It is responsible for disorders
such as <i>polymorphic light eruption, solar urticaria</i>, and it provokes the various <i>cutaneous porphyrias</i>. It also provokes (or at least aggravates) skin lesions of <i>lupus erythematosus</i> and may aggravate <i>rosacea</i> and some other <i>dermatoses</i>. Certain drugs, such
as demeclocycline, phenothiazines, or amiodarone, can cause photosensitivity.
All these conditions (as well as <i>sunburn</i>) may occur
after relatively short periods of exposure to the sun. Solar ultraviolet
irradiation may provoke attacks of recurrent herpes labialis (but
it is not known whether the effect of sunlight exposure is local or
systemic).</p><p>The effects of exposure over longer periods include <i>ageing changes</i> and more importantly the initiation of <i>skin cancer</i>.</p><p>Solar ultraviolet radiation is approximately 200–400 nm in wavelength.
The medium wavelengths (290–320 nm, known as UVB) cause <i>sunburn</i>. The long wavelengths (320–400 nm, known as UVA) are responsible
for many <i>photosensitivity reactions</i> and <i>photodermatoses</i>. Both UVA and UVB contribute to long-term <i>photodamage</i> and to the changes responsible for <i>skin cancer</i> and
ageing.</p><div id="_201045"><p>Sunscreen preparations contain substances that protect the skin against
UVA and UVB radiation, but they are no substitute for covering the
skin and avoiding sunlight. The sun protection factor (SPF, usually
indicated in the preparation title) provides guidance on the degree
of protection offered against UVB; it indicates the multiples of protection
provided against burning, compared with unprotected skin; for example,
an SPF of 8 should enable a person to remain 8 times longer in the
sun without burning. However, in practice, users do not apply sufficient
sunscreen product and the protection is lower than that found in experimental
studies.</p><p>Some manufacturers use a star rating system to indicate the
protection against UVA relative to protection against UVB for sunscreen
products. However, the usefulness of the star rating system remains
controversial. The EU Commission (September 2006) has recommended
that the UVA protection factor for a sunscreen should be at least
one-third of the sun protection factor (SPF); products that achieve
this requirement will be labelled with a UVA logo alongside the SPF
classification. Preparations that also contain reflective substances,
such as titanium dioxide, provide the most effective protection against
UVA.</p></div><p>Sunscreen preparations may rarely cause allergic
reactions.</p><div class="cN"><p>For optimum photoprotection, sunscreen preparations
should be applied <b>thickly </b>and <b>frequently</b> (approximately 2 hourly). In photodermatoses, they should be used
from spring to autumn. As maximum protection from sunlight is desirable,
preparations with the highest SPF should be prescribed.</p></div><div id="_207993"><div class="cBM" id="_tb0064">Ingredient nomenclature in sunscreen preparations</div><table class="table" summary="Ingredient nomenclature in sunscreen preparationsINCI synonyms, sunscreensInternational&#xA;nomenclature, cosmetic ingredients see INCI synonyms" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; border-left: 1pt solid ; border-right: 1pt solid ; "><colgroup><col style="text-align: left;" /><col style="text-align: left;" /></colgroup><thead><tr><th style="border-bottom: 1pt solid ; text-align: left;">rINN</th><th style="border-bottom: 1pt solid ; text-align: left;">INCI</th></tr></thead><tbody><tr><td style="border-bottom: 1pt solid ; text-align: left;">amiloxate</td><td style="border-bottom: 1pt solid ; text-align: left;">isoamyl <i>p</i>-methoxycinnamate</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">avobenzone</td><td style="border-bottom: 1pt solid ; text-align: left;">butyl methoxydibenzoylmethane</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">bemotrizinol</td><td style="border-bottom: 1pt solid ; text-align: left;">bis-ethylhexyloxyphenol methoxyphenyl triazine</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">bisoctrizole</td><td style="border-bottom: 1pt solid ; text-align: left;">methylene bis-benzotriazolyl tetramethylbutylphenol</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">ecamsule</td><td style="border-bottom: 1pt solid ; text-align: left;">terephthalylidene dicamphor sulfonic acid</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">ensulizole</td><td style="border-bottom: 1pt solid ; text-align: left;">phenylbenzimidazole sulfonic acid</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">enzacamene</td><td style="border-bottom: 1pt solid ; text-align: left;">4-methylbenzylidene camphor</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">octinoxate</td><td style="border-bottom: 1pt solid ; text-align: left;">octyl (<i>or</i> ethylhexyl) methoxycinnamate</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;">octocrilene</td><td style="border-bottom: 1pt solid ; text-align: left;">octocrylene</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-bottom: 1pt solid ; text-align: left;">oxybenzone</td><td style="border-bottom: 1pt solid ; text-align: left;">benzophenone-3</td></tr><tr><td style="border-bottom: 1pt solid ; text-align: left;" colspan="2">The European Commission Cosmetic Products Regulation (EC) 1223/2009 requires the use of INCI (International Nomenclature of Cosmetic Ingredients) for cosmetics and sunscreens. This table includes the rINN and the INCI synonym for the active ingredients of sunscreen preparations in the BNF</td></tr></tbody></table></div><div class="cAZ"><h2>Borderline substances</h2> <p class="cAX">The preparations marked
‘ACBS’ are regarded as drugs when prescribed for skin protection against
ultraviolet radiation in abnormal cutaneous photosensitivity resulting
from genetic disorders or photodermatoses, including vitiligo and
those resulting from radiotherapy; chronic or recurrent herpes simplex
labialis. Preparations with SPF less than 30 should not normally be
prescribed. See also <a title="BNF:target-block: Conditions (photodermatoses)" href="28830.htm#_201566">Appendix 2</a>.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="215371.htm" title="Anthelios®">Anthelios®</a></li><li><a href="86592.htm" title="Delph®">Delph®</a></li><li><a href="106182.htm" title="Sunsense® Ultra">Sunsense® Ultra</a></li><li class="jN" id="_6081" style="margin: 0 0 0 20px;"><h1 class="title">Uvistat®<span> (<a href="appendix-112803-L.htm#m671">LPC</a>)</span></h1><div class="cAY"><span class="cAB">Cream</span> (UVA and UVB protection; UVB-SPF
30), avobenzone 5%, bisoctrizole 1.5%, octinoxate 7.5%, octrocrilene
4%, titanium dioxide 5.2%, net price 125 mL = £7.45. ACBS<div class="cAO"><span class="cAG">Excipients </span> include disodium edetate, hydroxybenzoates (parabens), propylene
glycol</div><div class="cAV"><h3>Note</h3> <p class="cAX">For INCI synonyms, see table <a title="BNF:target-block: Ingredient nomenclature in sunscreen preparations table" href="6075.htm#_207993">above</a></p></div></div><div class="cAY"><span class="cAB">Cream</span> (UVA and UVB protection; UVB-SPF
50), amiloxate 2%, avobenzone 5%, bisoctrizole 6%, octinoxate 10%,
octrocrilene 4%, titanium dioxide 4.8%, net price 125 mL = £8.45.
ACBS<div class="cAO"><span class="cAG">Excipients </span> include disodium edetate, polysorbate 60,
propylene glycol</div><div class="cAV"><h3>Note</h3> <p class="cAX">For INCI synonyms, see table <a title="BNF:target-block: Ingredient nomenclature in sunscreen preparations table" href="6075.htm#_207993">above</a></p></div></div><div class="cAY"><span class="cAB">Lipscreen</span> (UVA and UVB protection;
UVB-SPF 50), avobenzone 5%, bemotrizinol 3%, octinoxate 10%, octocrilene
4%, titanium dioxide 3%, net price 5 g = £2.99. ACBS<div class="cAO"><span class="cAG">Excipients </span> include butylated
hydroxytoluene, hydroxybenzoates (parabens)</div><div class="cAV"><h3>Note</h3> <p class="cAX">For INCI synonyms, see table <a title="BNF:target-block: Ingredient nomenclature in sunscreen preparations table" href="6075.htm#_207993">above</a></p></div></div></li><li id="_57565"><a href="57565.htm" title="Photodamage">Photodamage</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="6074.htm">Previous: 13.8 Sunscreens and camouflagers</a> | <a class="top" href="6081.htm#">Top</a> | <a accesskey="]" href="57565.htm">Next: Photodamage</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>